KMD Bioscience Co., Ltd.
KMD Bioscience protein department combines our protein expression systems: prokaryotic expression systems, yeast expression systems, ma...
Read More
With the development of biotechnology, high-quality, high-specificity antibodies not only become an effective tool for protein identifi...
Read More
Molecular cloning (Molecular Cloning) refers to a group of molecules that are exactly the same as the ancestor molecule generated by th...
Read More
2019 novel coronavirus(2019-nCoV) infection has attracted worldwide attention since the end of 2019. SARS-CoV-2 is a novel virus that f...
Read More
KMD Bioscience offers custom alpaca polyclonal antibody and monoclonal antibody production services to the scientific community. Our capabilities enable us to pr...
Read More
Expression of recombinant proteins in E. coli is often the fastest and most cost-effective solution for recombinant protein production. KMD Bioscience leverages ...
Read More
KMD Bioscience has established and perfected four major protein expression platforms: Prokaryotic Expression Platform, Mammalian Cell Protein Expression Platform...
Read More
KMD Bioscience has extensive experiences of antibody development. Our scientists can provide comprehensive antibody downstream engineering services, including an...
Read More
KMD Bioscience has extensive experiences in antibody production, including monoclonal and polyclonal antibody production. We promise to provide high-performance ...
Read More
KMD Bioscience can provide two monoclonal antibody production protocols to meet clients' different needs: 1. Cell fusion technique: including mouse hybridoma...
Read MoreAs a national high-tech enterprise, KMD Bioscience CO. Ltd., is focusing on providing natural protein extraction and fermentation, customized recombinant protein expression services for global scientists and research institutions, mono- and poly- antibody production, phage display library construction and screening services. At the same time, based on our company's five mature core technology service platforms, we have successfully developed numerous recombinant proteins, antibodies..
Read More
More than a year since the outbreak of the SARS-CoV-2, several highly publicized new variants have been generated with mutations in the viral genome. Among them, 501Y.V1 (B.1.1.7), 501Y.V...
Read More
As SARS-CoV-2 pandemic continues, vaccine presents a key to mitigate and prevent disease. Pfizer, AstraZeneca are all vaccines have been put in use, including other kinds of operational v...
Read More
Introduce KMD's most recent review rewards program: as long as you reviewed "KMD Bioscience, Tianjin" in your article, please contact us or leave a message to submit, we will offer you a ...
Read More
The 2019 new coronavirus disease (COVID-19) epidemic caused by the virus SARS-CoV-2 is the third major epidemic in the past 20 years. SARS-CoV-2 is a member of the Coronaviridae family li...
Read More
